Literature DB >> 19483160

Regulation of serum hepcidin levels in sickle cell disease.

Joyce J C Kroot, Coby M M Laarakkers, Erwin H J M Kemna, Bart J Biemond, Dorine W Swinkels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19483160      PMCID： PMC2688584          DOI： 10.3324/haematol.2008.003152

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

Review 1.  Sickle-cell disease.

Authors:  Marie J Stuart; Ronald L Nagel
Journal:  Lancet       Date:  2004 Oct 9-15       Impact factor: 79.321

2.  Hepcidin and iron-loading anemias.

Authors:  Elizabeta Nemeth; Tomas Ganz
Journal:  Haematologica       Date:  2006-06       Impact factor: 9.941

3.  Sickle cell patients are characterized by a reduced glycocalyx volume.

Authors:  Eduard J van Beers; Max Nieuwdorp; Ashley J Duits; Ludo M Evers; John-John B Schnog; Bart J Biemond
Journal:  Haematologica       Date:  2008-02       Impact factor: 9.941

4.  Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.

Authors:  Erwin H J M Kemna; Harold Tjalsma; Vladimir N Podust; Dorine W Swinkels
Journal:  Clin Chem       Date:  2007-02-01       Impact factor: 8.327

Review 5.  Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction?

Authors:  Dorine W Swinkels; Joost P H Drenth
Journal:  J Hepatol       Date:  2008-08-21       Impact factor: 25.083

6.  Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.

Authors:  Soumeya Bekri; Philippe Gual; Rodolphe Anty; Nathalie Luciani; Monsef Dahman; Bala Ramesh; Antonio Iannelli; Aline Staccini-Myx; Dominique Casanova; Imed Ben Amor; Marie-Christine Saint-Paul; Pierre-Michel Huet; Jean-Louis Sadoul; Jean Gugenheim; Surjit Kaila S Srai; Albert Tran; Yannick Le Marchand-Brustel
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

7.  Urinary hepcidin in congenital chronic anemias.

Authors:  Susan L Kearney; Elizabeta Nemeth; Ellis J Neufeld; Dharma Thapa; Tomas Ganz; David A Weinstein; Melody J Cunningham
Journal:  Pediatr Blood Cancer       Date:  2007-01       Impact factor: 3.167

Review 8.  Hepcidin: from discovery to differential diagnosis.

Authors:  Erwin H J M Kemna; Harold Tjalsma; Hans L Willems; Dorine W Swinkels
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

9.  Regulation of hepcidin: insights from biochemical analyses on human serum samples.

Authors:  Erwin H J M Kemna; April E R Kartikasari; Lambertus J H van Tits; Peter Pickkers; Harold Tjalsma; Dorine W Swinkels
Journal:  Blood Cells Mol Dis       Date:  2007-11-26       Impact factor: 3.039

10.  Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry.

Authors:  Dorine W Swinkels; Domenico Girelli; Coby Laarakkers; Joyce Kroot; Natascia Campostrini; Erwin H J M Kemna; Harold Tjalsma
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240
  10 in total
  17 in total

1.  Sickle cell disease is associated with decreased HIV but higher HBV and HCV comorbidities in U.S. hospital discharge records: a cross-sectional study.

Authors:  Mehdi Nouraie; Sergei Nekhai; Victor R Gordeuk
Journal:  Sex Transm Infect       Date:  2012-05-24       Impact factor: 3.519

2.  Erythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease.

Authors:  Matthew S Karafin; Kathryn L Koch; Amy B Rankin; Debora Nischik; Ghady Rahhal; Pippa Simpson; Joshua J Field
Journal:  Blood Cells Mol Dis       Date:  2015-07-17       Impact factor: 3.039

Review 3.  Iron metabolism: interactions with normal and disordered erythropoiesis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

Review 4.  Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model.

Authors:  Tirthadipa Pradhan-Sundd; Gregory J Kato; Enrico M Novelli
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-27       Impact factor: 5.282

5.  Iron overload in sickle cell disease.

Authors:  Radha Raghupathy; Deepa Manwani; Jane A Little
Journal:  Adv Hematol       Date:  2010-05-17

6.  Role of cellular iron and oxygen in the regulation of HIV-1 infection.

Authors:  Sergei Nekhai; Namita Kumari; Subhash Dhawan
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

Review 7.  Physiology and pathophysiology of iron in hemoglobin-associated diseases.

Authors:  Thomas D Coates
Journal:  Free Radic Biol Med       Date:  2014-04-12       Impact factor: 7.376

8.  Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.

Authors:  Francesca Vinchi; Richard Sparla; Sara T Passos; Richa Sharma; S Zebulon Vance; Hala S Zreid; Hesham Juaidi; Deepa Manwani; Karina Yazdanbakhsh; Vijay Nandi; André M N Silva; Anand R Agarvas; Eitan Fibach; John D Belcher; Gregory M Vercellotti; Husam Ghoti; Martina U Muckenthaler
Journal:  Br J Haematol       Date:  2021-03-15       Impact factor: 6.998

9.  Iron metabolism in thalassemia and sickle cell disease.

Authors:  Raffaella Mariani; Paola Trombini; Matteo Pozzi; Alberto Piperno
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-10-27       Impact factor: 2.576

10.  Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Authors:  Bianca Maria Ricerca; Arturo Di Girolamo; Deborah Rund
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-28       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.